| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| lx2931 | sphingosine-1-phosphate lyase 1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Dermatologic disorders[MeSHID:D012871] Acantholysis[MeSHID:D000051] Rheumatoid Arthritis[MeSHID:D001172] |
127.3 | phase 2 | inhibitor |
| lx2931 | sphingosine-1-phosphate lyase 1 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Dermatologic disorders[MeSHID:D012871] Acantholysis[MeSHID:D000051] Rheumatoid Arthritis[MeSHID:D001172] |
127.3 | phase 2 | unknown |
| click here to return to the previous page | ||||||||